- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
E-Learning Module Helps Med Students Learn Radiation Protection
As imaging use has increased, so has the need for medical professionals to understand appropriate utilization and possible adverse effects of radiation exposure.
A medical school in Ireland has implemented an e-learning module to ensure students graduate with knowledge of radiation protection. As imaging use has increased, so has the need for medical professionals to understand appropriate utilization and possible adverse effects of radiation exposure.
The University Cork College in Cork, Ireland, developed and required fourth-year medical students to complete a radiation protection e-learning module. Researchers examined the results after the program was completed. Eighty-nine percent of the 127 medical students completed the e-module pre-test accurately and 99 percent completed the post-test accurately. The study was published in the March issue of the Journal of the American College of Radiology.
The use of e-modules as part of the curriculum allows the information on radiation protection to be added without overburdening the students with more lectures and tutorials, said Sum Leong, MD, lead author of the study.
“Combining e-learning and more traditional educational programs such as a clinical radiology rotation is likely to improve student experience,” he added.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
